|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C12P 21/08 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3485903 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18197338.9 |
| Date of filing the European patent application | 2012-09-24 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
| (46) | Date of publication of the claims translation | 2023-02-27 |
| (30) | Number | Date | Country code |
| 201161538454 P | 2011-09-23 | US | |
| 201261597409 P | 2012-02-10 | US | |
| 201261692978 P | 2012-08-24 | US |
| (72) |
GURNEY, Austin L. , US
SATO, Aaron Ken , US
BOND, Christopher John , US
|
| (73) |
Mereo BioPharma 5, Inc. ,
800 W El Camino Real
Suite 180, Mountain View, CA 94040,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | VEGF/ DLL4 surišantys agentai ir jų panaudojimas |
| VEGF/DLL4 BINDING AGENTS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 14 | 289.00 EUR |
| 2026-09-24 |